Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.

Wei, J; Costa, C; Shen, J; Yu, L; Sanchez, J J; Qian, X; Sun, X; Zou, Z; Gimenez-Capitan, A; Yue, G; Guan, W; Rosell, R; Liu, B

Wei, J; Costa, C; Shen, J; Yu, L; Sanchez, J J; Qian, X; Sun, X; Zou, Z; Gimenez-Capitan, A; Yue, G; Guan, W; Rosell, R; Liu, B.

Afiliação

Wei J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Costa C; Pangaea Biotech, USP Dexeus University Institute, Barcelona 08028, Spain.
Shen J; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Yu L; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Sanchez JJ; Department of Preventive Medicine and Public Health, Autonomous University of Madrid, Madrid 28049, Spain.
Qian X; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Sun X; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Zou Z; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Gimenez-Capitan A; Pangaea Biotech, USP Dexeus University Institute, Barcelona 08028, Spain.
Yue G; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Guan W; Department of General Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing 210008, China.
Rosell R; 1] Pangaea Biotech, USP Dexeus University Institute, Barcelona 08028, Spain [2] Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Medical Oncology Service, Badalona 08916, Spain.
Liu B; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.

Br J Cancer ; 110(11): 2662-8, 2014 May 27.

Article em En | MEDLINE | ID: mdl-24809779

Assuntos

Adenocarcinoma/metabolismo; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Histona-Lisina N-Metiltransferase/genética; Proteínas Repressoras/genética; Neoplasias Gástricas/metabolismo; Proteínas Adaptadoras de Transdução de Sinal; Adenocarcinoma/tratamento farmacológico; Adenocarcinoma/mortalidade; Adulto; Idoso; Idoso de 80 Anos ou mais; Proteína BRCA1/genética; Proteína BRCA1/metabolismo; Proteínas de Ciclo Celular; Docetaxel; Feminino; Fluoruracila/uso terapêutico; Expressão Gênica; Histona-Lisina N-Metiltransferase/metabolismo; Humanos; Peptídeos e Proteínas de Sinalização Intracelular/genética; Peptídeos e Proteínas de Sinalização Intracelular/metabolismo; Estimativa de Kaplan-Meier; Leucovorina/uso terapêutico; Masculino; Pessoa de Meia-Idade; Proteínas Nucleares/genética; Proteínas Nucleares/metabolismo; Compostos Organoplatínicos/uso terapêutico; Modelos de Riscos Proporcionais; RNA Mensageiro/genética; RNA Mensageiro/metabolismo; Proteínas Repressoras/metabolismo; Neoplasias Gástricas/tratamento farmacológico; Neoplasias Gástricas/mortalidade; Taxoides/administração & dosagem; Transativadores/genética; Transativadores/metabolismo; Proteína 1 de Ligação à Proteína Supressora de Tumor p53; Enzimas de Conjugação de Ubiquitina/genética; Enzimas de Conjugação de Ubiquitina/metabolismo; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Histona-Lisina N-Metiltransferase Tipo de estudo: Prognostic_studies Limite: Aged80 Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google